Announced
Financials
Tags
United States
cancer treatment
Biotechnology
Acquisition
Domestic
Public
Majority
Tender Offer
Pending
Private Equity
Friendly
Single Bidder
Synopsis
Tang Capital-backed Concentra Biosciences, a biotech company, agreed to acquire Theseus Pharmaceuticals, a clinical-stage biopharmaceutical company, for $188m. Theseus shareholders holding approximately 59% of Theseus common stock have signed support agreements under which such shareholders agreed to tender their shares in the Offer and support the merger.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.